Skip to content

Enterprise value at other companies

Baxter International logo
Baxter InternationalBAX
$6.88B-55.6%
Boston Scientific logo
Boston ScientificBSX
$141.04B-1.0%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$4.43B-33.3%
Medtronic logo
MedtronicMDT
$131.22B-3.2%
Abbott logo
AbbottABT
$205.65B-13.1%
Cytokinetics logo
CytokineticsCYTK
$8.41B+70.7%

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.44B+16.0%
P/S4.4×-0.4×

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.5×-0.5×
Current ratio5.2×-0.5×

Where this comes from

Calculated from iRhythm Holdings, Inc. ’s reported figures.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's enterprise value?
iRhythm Holdings, Inc. (IRTC) reported enterprise value of $3.64B in Q1 2026.
How has iRhythm Holdings, Inc. 's enterprise value changed year-over-year?
iRhythm Holdings, Inc. 's enterprise value increased by 21.8% year-over-year, from $2.99B to $3.64B.
What is the long-term trend for iRhythm Holdings, Inc. 's enterprise value?
Over 5 years (2020 to 2025), iRhythm Holdings, Inc. 's enterprise value has grown at a -4.6% compound annual growth rate (CAGR), from $7.01B to $5.55B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.